Bumper Offer - Urjas oil Just @ Rs. 1
Telma-CT 40/6.25 Tablet (15) is a prescription drug, available for use as Tablet. Telma-CT 40/6.25 Tablet (15) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Telma-CT 40/6.25 Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Telma-CT 40/6.25 Tablet (15) include Dizziness, Nausea or vomiting, Back Pain. Apart from the aforementioned side effects, Telma-CT 40/6.25 Tablet (15) can also lead to other problems, which have been listed below. These side effects of Telma-CT 40/6.25 Tablet (15) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Telma-CT 40/6.25 Tablet (15) has a Mild effect for pregnant women and Mild effect on lactating mothers. In addition, Telma-CT 40/6.25 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Telma-CT 40/6.25 Tablet (15) related warnings section.
Individuals suffering from medical conditions like Angioedema, Hyperkalemia, Drug Allergy must refrain from the use of Telma-CT 40/6.25 Tablet (15) since this can cause severe adverse effects. Other conditions have been mentioned below in the Telma-CT 40/6.25 Tablet (15) contraindications section.
Drug interactions for Telma-CT 40/6.25 Tablet (15) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Telma-CT 40/6.25 Tablet (15) is not safe while driving, and is not addiction.
Telma-CT 40/6.25 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Telma-CT 40/6.25 Tablet (15) is used -
Severe
Mild
Common
Is the use of Telma-CT 40/6.25 Tablet (15) safe for pregnant women?
Pregnant women can consume [medicine]. Though Telma Ct has mild side effects when taken during pregnany
Is the use of Telma-CT 40/6.25 Tablet (15) safe during breastfeeding?
Side effects of Telma Ct for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Telma-CT 40/6.25 Tablet (15) on the Kidneys?
Telma Ct rarely affects the kidneys.
What is the effect of Telma-CT 40/6.25 Tablet (15) on the Liver?
Telma Ct is rarely harmful for the liver.
What is the effect of Telma-CT 40/6.25 Tablet (15) on the Heart?
Telma Ct is rarely harmful for the heart.
Telma-CT 40/6.25 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telma-CT 40/6.25 Tablet (15) unless your doctor advises you to do so -
Is this Telma-CT 40/6.25 Tablet (15) habit forming or addictive?
Forming a habit of Telma-CT 40/6.25 Tablet (15) has not been reported.
Interaction between Food and Telma-CT 40/6.25 Tablet (15)
When consumed with certain foods, Telma-CT 40/6.25 Tablet (15) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Telma-CT 40/6.25 Tablet (15)
Consuming Telma-CT 40/6.25 Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
